We construct composite indices of the health status in the 8 HSE regions of Ireland in 2010.
Introduction
refer to Health as "… the state of complete physical, mental and social wellbeing and not merely the absence of disease or infirmity" and describe it as a "… positive concept, emphasizing social and personal resources as well as physical capabilities". Health indicators, rooted in conceptual models of what influences health status 1 , help us map the achievement over time of health goals and to compare different geographic areas and regional populations. International 2 , national 3 and regional 4 organizations routinely construct many health indicators, whose composition and variety reflect their intended purpose and use. The aim of this study is to construct composite indices of population health status in the 8 HSE regions of Ireland. Our composite index is sufficiently broad to enable inter-regional comparisons: its component indicators are sufficiently detailed to track the main sources of inter-regional difference. The indicators shorten the distance to the WHO ideal, have wide application and a role to play in policy formation.
Methods
1 See Wold 2008. 2 For example, the OECD and WHO. 3 See, for example, Statistics Canada and the Canadian Institute for Health Information. The Health Protection Surveillance Group, HSE (2012) provides prevalence rates for specific diseases at regional level in Ireland. IPH provides disease prevalence rates at county level and CSO for 21 doctor diagnosed medical conditions. 4 For example Manitoba Centre for Health Policy. 5 Wold 2008, p.25 provides a list of indicators and data sources in common usage in the US. The first step in constructing a composite index 6 is to settle its scope i.e. the number of dimensions it will contain. These are governed by purpose and use and often are pragmatically constrained by the data available for their construction. Our composite indexthe CPS Composite Health Index (CHI), has 6 dimensions. The first 5 correspond to health conditions for which: (i) Alimentary Tract and Metabolism (ii) Cardiovascular system (iii)
Nervous system (iv) Respiratory system (v) Various anatomical therapeutic chemical (ATC) drugs 7 are prescribed; the sixth to health conditions for which the remaining 9 first level ATC therapeutic drug groups (combined in a single (vi) Other category) are prescribed.
The 24 therapeutic drug groups in these 6 ATC categories are set out in Table 1 and account for around 80% of all community drug prescriptions in 2010.
We associated one or more major health condition 8 with each therapeutic drug group and tabulated their prevalence rates. We did this separately for each of the 24 therapeutic groups in the 6 ATC categories and for each of the 8 HSE regions.
We did this by aggregating the county-level prevalence rates of 14 medical conditions and/or associated hospital admissions/operations together with 8 associated contributory factors into population-weighted regional indexes. We used 8 regional indicators for medical and/or associated consultations/hospital admissions, having adjusted the CSO regional indicators to conform to HSE-defined regions; Table A in the appendix sets out the details and gives the data sources.
When two or more health indicators were available for the same therapeutic group of drugs we used their geometric mean. For example, since 'Drugs for bone disease' are required for clinically diagnosed back conditions, osteoarthritis and osteoporosis we took their geometric as our composite 'bone disease' prevalence rate. We then 'normalised' or anchored each regional prevalence rate by dividing it into the corresponding national prevalence rate and multiplying by 100.
For each ATC sub-index we then took the geometrically weighted average of these normalised rates, weighting them by their prescribing shares in that ATC group. For example, the 'Other' ATC sub-index contains 5 therapeutic drug groups and has the form, 6 Gaye (2007) sets out the steps to be taken in constructing composite indices. 7 These are WHO first level ATC therapeutic group categories. For a brief history of the ATC classification system see http://www.whocc.no/atc_ddd_methodology/history/ 8 or other indicators, where appropriate. 3 12 
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is the prevalence of 'bone disease' in that region relative to the national rate: the other p values are similarly defined.
PCRS data 9 show that in 2010 'Drugs for Bone Disease' accounted for 8.01% and 'Antiinflammatory and Rheumatic' medicines accounted for 17.81% of GMS prescriptions in the 5 'Other' therapeutic groups covered. Hence, 4 .0801 w  , 5 .1781 w  and 5
Our composite GMS health indicator is the geometric average of the 6 ATC sub indices, 3 5
, where the weights are the GMS prescribing shares of each ATC group set out in Table 1 .
We repeated this exercise, using the weights set out in Table 1 to derive separate composite health indicators for the remaining DP and LTI community drug schemes. Finally, we constructed the geometric average of these scheme-specific composite health indicators for each region using the scheme coverage rates of that region as weights. For example, the GMS scheme coverage rate of 28% in the East region so the GMS composite health indicator is assigned a weight of .28: the DP scheme weight is .68; LTI is .04. The scheme coverage weights used in each region are given in Table 2 . For convenience we refer to the resulting general CPS Composite Health Index as CHI 10 . The relative frequencies of the major health conditions it contains reflect regional epidemiology and its construction embeds differences in the regional coverage of community drug schemes. Figure 3 identifies the regions with the best and the worst health status in each ATC category when compared to the national average and the size of the gaps between them. Respiratory health displays the greatest health gap but, as noted above, has a low CHI index weight of 7.99%, which lessens its contribution to inter-regional health gaps. Sizable inter-regional gaps in mental (CNS) and cardiovascular health also exist: these have high index weights and contribute significantly to inter-regional health gaps. Figure 3 highlights that the Midlands has the worst ill health prevalence in 4 out of the 6 ATC categories, whereas 4 different regions share the best health status in the 6 ATC categories (the East is best in 3 of the high weighted ATC categories, Alimentary Tract, CNS and Cardiovascular). Note also that while the Mid-West has the second best overall health status, it has best status in only 1 ATC category -Respiratory health -which has a low index weight.
Results

Figure 3
It is tempting to attribute specific health gaps to specific causes. The Midlands, for example, has high rates of asthma and respiratory ill-health that may partly result from regional climatic factors connected to its status as the sole non-coastal inland region. But such specific accounts leave its wider ill-health status unexplained, for example, it's very high rates of cholesterol and hospital admission for circulatory disease cardiovascular.
It is similarly tempting to promote general causes of differences in inter-regional health. Table 3 shows that good health is well correlated with regional income. Surprisingly, it is better correlated with unadjusted disposable income per capita (R 2 = 0.74) than with equivalised net disposable income (R 2 = 0.53) and is inversely and moderately well correlated (R 2 = .54) with the share of the regional population aged over 65. We therefore expect that these key demographic and socio-economic variables will provide, at best, a partial and incomplete account of regional variations in good health.
Moreover, the pattern of causality is complex. The below-average health status regions -Midlands, North-West, West 16 , and South East have low incomes and, apart from the Midlands, tend to have high population shares aged over 65. They tempt us to cite poor socioeconomic conditions and unfavourable demographics as general sources of inter-regional health differences. However, while 4 regions with low income and poor demographics have the poorest health the converse is not true. The Eastern region has the highest income and lowest elderly population share, but the Mid-West, which ranks a close second, has an income of around €1,000 less than the East and has a population share aged over 65 (i.e. 11.8%) that is nearly 2 percentage points higher than the East. Similarly, the Western region has higher net disposable income and substantially less favourable demographics than the Midlands but has a better health status.
Perhaps, socio-economic and demographic factors exert non-linear threshold effects on health status: it is no less likely that other confounding health, life-style and other medical variables also play a significant role.
The North West has the highest GMS coverage rate in Ireland, at roughly 49-50%, almost 10% higher than the Midlands which has a GMS coverage rate of 38%. Hence despite its poor health status the Midlands has less favourable access to GMS health services which may contribute to its poor health status.
Discussion and Conclusions
Our CHI index adopts World Bank, UNDP and EU index construction methodology and conforms to their guidelines (Gaye 2007; IMF, 2010; OECD 2008) . The 30 Illness/ill-health indicators that make up its 6 ATC sub-indices are sampled and reported by the primary statistics agencies the IPH, CSO and PCRS and most of the underlying statistics are sampled and reported at county level. We make these observations;
First, most noticeable to us in constructing CHI is the lack of a key indicator for 'Alimentary Tract and Metabolism'. It is also true that CHI falls short of the World Bank ideal by dealing with ill-health rather than health and excludes positive medical interventions, such as immunization.
Second, it might be contended that prescribing value rather than prescribing frequency weights should be used but both yield broadly similar and robust CHI values.
Third, as with any summary indicator the sample weights and coverage might fruitfully be modified depending on their intended application. The CHI also under-represents conditions that do not employ drug therapy and excludes hospital-originated HTD prescribing (e.g.
Antineoplastic & Immunomodulating Agents drugs group). For example, if we wished to map primary care need we might usefully expand CHI and adjust its component weights to include pregnancy and immunization services, depending on application, we might also wish to scrutinize its disaggregated components.
Our findings indicate sizable disparities in overall health status of Irish regions. We have tabulated the main categories of health conditions and outcomes that are the source of these disparities. For example, cardiovascular health has the largest weight in the CHI index:
improving it offers the greatest scope for improving national health status. As yet, we cannot isolate the separate contributions socio-economic, demographic, lifestyle and medical factors make to the observed outcomes. Equally, we need to extend CHI over a number of years to assess how health status is changing nationally over time.
